Pharmatimes Online. 15 May 2013 The pharmaceutical industry has now entered the Outcomes Era where compounds must supply convincing evidence of a new drug’s value, with proof of the best possible health outcomes and additional benefits if it is to achieve attractive price and reimbursement levels, says new research.As many as 60% of pharmaceutical executives […]
